Prevention of Future Deaths reports · 2024

Tracy McCarthy

Regulation 28 report to prevent future deaths, reference 2024-0280, written 21 May 2024. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report21 May 2024
Reference2024-0280
DeceasedTracy McCarthy
CoronerIan Potter
Coroner areaInner North London
CategoryAlcohol, drug and medication related deaths
Sourcejudiciary.uk record · original PDF
Responses published1

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

Regulation 28: Prevention of Future Deaths report 

Tracy Frances MCCARTHY (died 15 July 2023) 

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO: 

1.  The GP Partners 

The Tredegar Practice 
35 St Stephen’s Road 
London 
E3 5JD 

1  CORONER 

I am Ian Potter, assistant coroner, for the coroner area of Inner North London. 

2  CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice 
Act 2009 and Regulations 28 and 29 of the Coroners (Investigations) 
Regulations 2013. 

3 

INVESTIGATION and INQUEST 

On 1 August 2023, an investigation was commenced into the death of TRACY 
FRANCES MCCARTHY, then aged 50 years. The investigation concluded at 
the end of an inquest, heard by me, on 15 May 2024. 

The inquest conclusion was ‘drug-related death’. The medical cause of death 
was: 

1a amitriptyline toxicity 
II coronary artery disease 

4  CIRCUMSTANCES OF DEATH 

Tracy McCarthy was found deceased at her home address on 17 July 2023. 
She died as a result of her long-term misuse of amitriptyline.  

5  CORONER’S CONCERNS 

During the course of the inquest the evidence revealed matters giving rise to 
concern. In my opinion, there is a risk that future deaths could occur unless 
action is taken. In the circumstances, it is my statutory duty to report to you. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The MATTERS OF CONCERN are as follows: 

(1) Although Amitriptyline is not generally regarded as a drug of abuse, Ms 
McCarthy was known to be dependent on it. She had been prescribed 
Amitriptyline for many years, and at one stage in or about 2022, she 
was regularly prescribed 
mg per day, which is over the maximum 
suggested dose in the BNF (150mg per day). In addition, the BNF 
provides a clear warning (as did the prescribing/records software in use 
at The Tredegar Practice) that Amitriptyline prescribed for depression 
(which it was in this case), is “not recommended – increased risk of 
fatality in overdose”. A GP from The Tredegar Practice told me that 

mg was an “unacceptable dose”. 

The concern being that guidelines were not followed, particularly in 
relation to a patient known to be dependent and where use of 
Amitriptyline was not recommended for the presenting condition in any 
event. 

(2) Following Ms McCarthy’s admission to hospital as a result of an 

overdose of Amitriptyline and Codeine, The Tredegar Practice received 
information from the hospital, making reference to the overdose. 
Despite this, the risk was not flagged and no alert was put on the 
system; as such, the prescription of Amitriptyline continued. A GP from 
The Tredegar Practice told me, “[the Amitriptyline] should have been 
stopped, but knowing [the patient] that would have been very hard to 
do.” 

(3) Ms McCarthy’s Amitriptyline prescriptions had previously been issued 

on a daily basis, to mitigate the risk of overdose. However, following her 
admission to hospital (mentioned above) a GP at The Tredegar Practice 
took the decision to reduce the dose slightly, but transfer to monthly 
prescriptions, thereby allowing Ms McCarthy access to 28 days’ worth 
of Amitriptyline all at once. A GP from The Tredegar Practice told me 
that they thought this was “risky” but said that the GP who made that 
decision was not familiar with the patient and maybe wouldn’t have 
known the rationale for daily prescriptions. They also told me that the 
Practice was probably “over-reliant on the knowledge of particular 
doctors that treated her.” 

The concern is that too great an emphasis was placed on the 
knowledge of a few individuals, which led to acknowledged risks not 
being put in the records in a way that would alert any practitioner to 
them. 

6   ACTION SHOULD BE TAKEN 

In my opinion, action should be taken to prevent future deaths and I believe 
you have the power to take such action. 

7   YOUR RESPONSE 

 
 
 
 
 
 
 
 
 You are under a duty to respond to this report within 56 days of the date of this 
report, namely 16 July 2024. I, the coroner, may extend the period. 

Your response must contain details of action taken or proposed to be taken, 
setting out the timetable for action. Otherwise, you must explain why no action 
is proposed. 

8  COPIES and PUBLICATION 

I have sent a copy of this report to the Chief Coroner and to the following 
Interested Person: 

(a) 

 – daughter of the deceased 

I have also sent a copy to following, for information: 

-  The Care Quality Commission. 

I am also under a duty to send the Chief Coroner a copy of your response. 

The Chief Coroner may publish either or both in a complete or redacted or 
summary form. He may send a copy of this report to any person who he 
believes may find it useful or of interest. You may make representations to me, 
the coroner, at the time of your response, about the release or the publication 
of your response by the Chief Coroner. 

9 

Ian Potter 
HM Assistant Coroner, Inner North London 
21 May 2024

Responses

1 response published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from The GP Partners (PDF)
, FRCGP 
, MRCGP 
, FRCGP 
, MRCGP 
, MRCGP 
, MRCGP 

11 July 2024 

The Tredegar Practice 
35 St Stephens Road 
London E3 5JD 

Mr Ian Potter 
HM Assistant Coroner 
Inner North London 

Dear Mr Potter, 

re: Regulation 28: Prevention of Future Deaths report; Tracy Frances  
McCarthy (died 15 July 2023) 

Thank-you for your communication of 21 May 2024 relating to the death and inquest 
into the death of Tracy McCarthy. 

Your request for a response by us regarding action to be taken to prevent future deaths 
or risks is welcome and gives us an opportunity to review this sad case and identify 
ways of improving the safety and quality of our processes and patient care.  

I was the lead GP for care with Tracy until my retirement from clinical practice in 
September 2022. At that time, I had a limited number of patients with complex 
problems on my caseload and I took action to handover to my colleagues. Tracy was 
certainly one of these patients, perhaps the most complex. I was very sad to hear of 
Tracy’s death, but I was not aware of the findings of your inquest until your 
communication. 

As a result, I have looked through her notes and met with two of my GP colleagues (

 and 

) who have had the most (but not only) contact with Tracy 

following my retirement. We have reviewed the notes and agree that there are a 
number of gaps and failings in the notes management that led to the amitriptyline 
prescription being issued that was, in Tracy’s case, the wrong thing to do. I would say 
that I feel the most accountable in this case as the essential thing in this case was that 
the essential information be visible to all GPs managing Tracy’s care (and not just the 
person taking the lead).  

What was lacking to me as a retiring GP (and is still lacking) is a framework for creating 
a document for complex patients like Tracy so that any GP would be aware of the 
essentials of that patient’s history without having to search through the notes.  

It must be said that there is already in place a framework for certain patients (multi-
morbidity, usually elderly). These patients have an annual review from which emerges a 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Care Plan for the coming year (the patient is actively involved in the creation of this care 
plan). But this applies to a limited number of patients, and Tracy was not in this cohort. 

How to fill this gap? My initial thought was to create a ‘handover’ template to be 
completed when one GP retires or leaves the practice. As I was drafting this letter to you 
and the template, it became clear that something else was required. Not a document 
created when the lead GP retires or leaves the practice, but a document that is created, 
for this category of patients, in real time, in the present, to serve as a resource now, not 
waiting for a GP to retire.  

The proposed framework 

By framework I mean a process involving a number of elements: a clear purpose; 
training; documentation; planned review; quality assurance (is the process being 
carried out reliably, as intended?); quality control (are improvements to the process 
needed?). 

This framework has been created iteratively, and there will be further iterations (to 
improve it, to develop it). 

Purpose 

To provide a clear, readily accessible summary for complex patients to aid in safe and 
good quality planning and care for these patients. It is meant as an aid to assessment, a 
tool for review, and an aid to collaborative care by clinical staff. 

Rationale 

This framework has been designed in response to an avoidable patient death in a 
patient with complex health problems and behaviours. A major problem identified was 
lack of clear information to guide clinical staff who were not aware of the full picture. 
The information was in the notes, but not readily accessible, not readily visible. 

This framework was initially conceived as a ‘handover document’ to be used if a GP who 
led in the care of a complex patient retired or left the practice. It then became evident 
that this document was needed from the start, not when a GP left the practice.  

The Process 

1. All GPs, practice nurses, nurse practitioners, and other clinical staff working at the 
practice be aware of the framework and its rationale. Locum GPs will also need to be 
aware of the framework. This will require a systematic training. (It should be possible 
for this to be done efficiently, without adding significantly to the staffs’ considerable 
workload.) 

2. Identification of patients to be entered into the framework.  

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 What sort of cases should be considered? Complex patients with increased risks; 
patients who have a lead GP; patients in whom sharing information is important; 
patients in whom having a ‘global’ understanding is important. 

3. Each appropriate patient is added to the Risk Management & Care Planning 
Register (see separate document):  

a.  the lead GP will fill in the Risk Management & Care Plan (see separate 

document); the completed Care Plan will be filed in the patient’s Documents 
page.  

b.  In the EMIS patient record: in the Active Problem List add the SNOWMED 
Code Risk management administration (as Active; Significant, Permanent); 
in the free text space give name of lead GP, and the date of the Risk 
Management & Care Plan document. The purpose of this entry in the 
Problem List is to flag for any consulting GP (or other clinical member of 
staff) that this patient has complex needs and possible risks and signposts the 
Risk Management & Care Plan (which is designed to highlight and 
summarise the issues that a consulting clinician needs to keep in mind. This 
would also be of help to a GP doing repeat prescriptions). Of course, other 
clinicians, such as a pharmacist, would have access to this resource. 

c.  One thought would be that a copy of the most up-to-date Care Plan could be 
kept by the patient in case they are admitted to hospital. It might be helpful 
to include the Care Plan when referring the patient to hospital or community 
services. 

d.  The Risk management administration code will be added to the EMIS Alert 
flag list. (This alert is a pop-up in the bottom right of the patient’s record). 

3

 
 
 
 
 
 
 
 
 
 4.  Reviews: regular reviews will be needed in the process. 

Proposed reviews (subject to change in light of experience): 

a.  Overview of the Register quarterly. This is to give a sense of the scale and which 
patients are on the Register. This may trigger GPs (or other staff) to suggest a 
patient to be added.  

b.  Each GP lead will review their patients on the list 6 monthly (more frequently if 
need arises; an hospital admission should trigger a review). This will entail a 
review of the Risk Management & Care Plan and documenting the review in 
the Care Plan1. The updated copy to be filed on the date of review, and that (new) 
document will be signposted in the Problem List (that is, it is the most recent 
version that is signposted).  
One important consideration: in some cases, it may be useful/necessary to 
review the patient’s conditions and management with a colleague, or as a group 
of GPs (as in the GP Shared meeting). Having a ‘fresh set of eyes’ can often help. 

c.  A review of the overall framework/process to take place 6 monthly. The two 

questions to be asked: What is working well? What could be improved? 
Feedback will be given by the GP leads but also potentially by other clinicians 
who may have found the Risk Management & Care Planning framework 
helpful and may have suggestions for further development. 

d.  These reviews will need to be minuted, and these minutes circulated. 

5. To ensure that this framework remains active and effective, a GP lead for the 
framework/process will be appointed. The role of this GP will be to ensure that the 

1 This review and update will take into account possible changes in the patient’s circumstances, changes 
to the prescribed drugs, interventions, and so on. It will also be an opportunity to review the 
management. 

4

 
 
 
 
 
 
 
 
 
 reviews are taking place, making sure they are being scheduled, and making sure that 
the reviews are documented and that actions are actioned. This will not involve much 
work but will act as a reminder to ensure that this important work does not get 
forgotten, neglected. 

* 

This draft has been reviewed by 
the next GP Shared meeting (17 July 2024). Additional suggestions are likely to arise, 
and the next iteration of the framework will be created, and steps taken to implement 
the framework. 

. It will be presented at 

 and 

I would suggest that I provide you with an update and report of the implementation 
towards the end of September 2024. 

It has been suggested that we use this case in a presentation with GP colleagues, 
possibly on a PCN level, or among practices in Tower Hamlets. 

You may well have additional suggestions to make in light of this initial proposal. 

We are all saddened and chastened by this human tragedy. I hope we can learn 
important lessons from this review and the steps we will take so as to improve patient 
safety and quality of care going forward. 

Yours sincerely, 

GP Partner 

5

Related reports

Other reports by Ian Potter

See all →

More reports categorised “Alcohol, drug and medication related deaths”

See all →

Track Alcohol, drug and medication related deaths

See every Prevention of Future Deaths report matching Alcohol, drug and medication related deaths, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.